DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a complex condition that displays heterogeneity in disease severity and response to standard treatments between patients. Failure rates for conventional, target synthetic, and biologic disease-modifying rheumatic drugs (DMARDs) are significant. Although there are models...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Susan Siyu, Lewis, Myles J., Pitzalis, Costantino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377185/
https://www.ncbi.nlm.nih.gov/pubmed/37509625
http://dx.doi.org/10.3390/biomedicines11071987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377185/
https://www.ncbi.nlm.nih.gov/pubmed/37509625
http://dx.doi.org/10.3390/biomedicines11071987

Ejemplares similares